Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25681-06-5

25681-06-5

Post Buying Request

25681-06-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25681-06-5 Usage

Uses

Indolo[2,3-b]quinoxalin-6-yl-acetic Acid can be used to treat anemia.

Check Digit Verification of cas no

The CAS Registry Mumber 25681-06-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,8 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 25681-06:
(7*2)+(6*5)+(5*6)+(4*8)+(3*1)+(2*0)+(1*6)=115
115 % 10 = 5
So 25681-06-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H11N3O2/c20-14(21)9-19-13-8-4-1-5-10(13)15-16(19)18-12-7-3-2-6-11(12)17-15/h1-8H,9H2,(H,20,21)/p-1

25681-06-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-indolo[3,2-b]quinoxalin-6-ylacetic acid

1.2 Other means of identification

Product number -
Other names Indolo[2,3-b]quinoxalin-6-yl-acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25681-06-5 SDS

25681-06-5Upstream product

25681-06-5Downstream Products

25681-06-5Relevant articles and documents

Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents

Klimenko, Kyrylo,Lyakhov, Sergey,Shibinskaya, Marina,Karpenko, Alexander,Marcou, Gilles,Horvath, Dragos,Zenkova, Marina,Goncharova, Elena,Amirkhanov, Rinat,Krysko, Andrei,Andronati, Sergei,Levandovskiy, Igor,Polishchuk, Pavel,Kuz'min, Victor,Varnek, Alexandre

, p. 3915 - 3919 (2017)

This paper describes computer-aided design of new anti-viral agents against Vaccinia virus (VACV) potentially acting as nucleic acid intercalators. Earlier obtained experimental data for DNA intercalation affinities and activities against Vesicular stomatitis virus (VSV) have been used to build, respectively, pharmacophore and QSAR models. These models were used for virtual screening of a database of 245 molecules generated around typical scaffolds of known DNA intercalators. This resulted in 12 hits which then were synthesized and tested for antiviral activity against VaV together with 43 compounds earlier studied against VSV. Two compounds displaying high antiviral activity against VaV and low cytotoxicity were selected for further antiviral activity investigations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25681-06-5